Oral Potentially Malignant Disorders (OPMD): What is the clinical utility of dysplasia grade?

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancer in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Kalavrezos N, Scully C. Mouth cancer for clinicians Part 3: risk factors (traditional: tobacco). Dental Update. 2015;42(5):476–483.
   PubMedGoogle Scholar
• Secretan B, Straif K, Baan R, et al. A review of human carcinogens–Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009 Nov;10(11):1033–1034.
   PubMed Web of Science ®Google Scholar
• Holmstrup P, Vedtofte P, Reibel J, et al. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006 May;42(5):461–474.
   PubMed Web of Science ®Google Scholar
• Rock LD, Rosin MP, Zhang L, et al. Characterization of epithelial oral dysplasia in non-smokers: first steps towards precision medicine. Oral Oncol. 2018;78:119–125.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhao Y. Human papillomavirus infection in oral potentially malignant disorders and cancer. Arch Oral Biol. 2017;83:334–339.
   PubMed Web of Science ®Google Scholar
• De La Cour CD, Sperling CD, Belmonte F, et al. Human papillomavirus prevalence in oral potentially malignant disorders: systematic review and meta-analysis. Oral Dis. 2020 Mar 6. 10.1111/odi.13322. Online ahead of print.1–8.
   Google Scholar
• Gupta S, Gupta S. Role of human papillomavirus in oral squamous cell carcinoma and oral potentially malignant disorders: a review of the literature. Indian J Dent. 2015;6(2):91–910.
   PubMedGoogle Scholar
• McCord C, Xu J, Xu W, et al. Association of high-risk human papillomavirus infection with oral epithelial dysplasia Oral Surgery, Oral Medicine. Oral Pathol Oral Radiol. 2013;115(4):541–549.
   PubMed Web of Science ®Google Scholar
• Woo SB, Cashman EC, Lerman MA. Human papillomavirus-associated oral intraepithelial neoplasia. Mod Pathol. 2013;26(10):1288–1297.
   PubMed Web of Science ®Google Scholar
• Machado J, Reis PP, Zhang T, et al. Low prevalence of Human Papillomavirus in oral cavity carcinomas. Head Neck Oncol. 2010;2(1):6. Article 6.-Article.
   PubMedGoogle Scholar
• Ganesh D, Sreenivasan P, Ohman J, et al. Potentially malignant oral disorders and cancer transformation. Int Inst Anticancer Res. 2018;38(6):3223–3229.
   PubMed Web of Science ®Google Scholar
• Khan N, Bavle RM, Makarla S, et al. “SKILL to KILL” - Oral cancer and potentially premalignant oral epithelial lesions (PPOELs): a survey approach Emerging of a new system and professionals. J Oral Maxillofac Pathol. 2019;23(2):248–256.
   PubMedGoogle Scholar
• Nikitakis NG, Pentenero M, Georgaki M, et al., Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: current knowledge and future implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 125(6): 650–669. 2018.
   PubMed Web of Science ®Google Scholar
• Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):612–627.
   PubMed Web of Science ®Google Scholar
• Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, et al. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. Online ahead of print. 2020 Oct 31. 10.1111/odi.13704.
   Web of Science ®Google Scholar
• Miranda-Filho A, Bray F. Global patterns and trends in cancers of the lip, tongue and mouth. Oral Oncol. 2020Mar;102:104551.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Udaltsova N, Engels EA, et al. Oral Leukoplakia and Risk of Progression to Oral Cancer: a Population-Based Cohort Study. JNCI. 2020;112(10):1047–1054.
   PubMedGoogle Scholar
• Holmstrup P, Oral erythroplakia—What is it? Oral Dis. 2018;24(1–2):138–143.
   PubMedGoogle Scholar
• Reichart PA, Philipsen HP. Oral erythroplakia - A review. Oral Oncol. 2005;41(6):551–561.
   PubMed Web of Science ®Google Scholar
• Shi L, Jiang W. Liu W Retrospective analysis of oral erythroplakia focused on multiple and multifocal malignant behavior. Oral Dis. 2019;25(7):1829–1830.
   PubMed Web of Science ®Google Scholar
• Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003;39(8):770–780.
   PubMed Web of Science ®Google Scholar
• Reibel J, Gale N, Hille J, et al. Oral potentially malignant disorders and oral epithelial dysplasia. In: El-Naggar AK, Chan JKC, Grandis JR, et al., editors. World Health Organization, Head and Neck tumours: tumors of the oral Cavity and Mobile Tongue. 4th ed Lyon, France: IARC; 2017. p. 112–115.
   Google Scholar
• Villa A, Sonis S. Oral leukoplakia remains a challenging condition. Oral Dis. 2018;24(1–2):179–183.
   PubMed Web of Science ®Google Scholar
• Warnakulasuriya S. Oral potentially malignant disorders: a comprehensive review on clinical aspects and management. Oral Oncol. 2020;102:104550. 102:104550.
   PubMed Web of Science ®Google Scholar
• Müller S. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):591–602.
   PubMed Web of Science ®Google Scholar
• Woo SB. Oral Epithelial Dysplasia and Premalignancy. Head Neck Pathol. 2019;13(3):423–439.
   PubMed Web of Science ®Google Scholar
• Darling MR, McCord C, Jackson-Boeters L, et al. Markers of potential malignancy in chronic hyperplastic candidiasis. J Investig Clin Dent. 2012;3(3):176–181.
   PubMedGoogle Scholar
• Giuliani M, Troiano G, Cordaro M, et al. Rate of malignant transformation of oral lichen planus: a systematic review. Oral Dis. 2019;25(3):693–709.
   PubMed Web of Science ®Google Scholar
• Thomson PJ, Goodson ML, Smith DR. Potentially malignant disorders revisited—The lichenoid lesion/proliferative verrucous leukoplakia conundrum. J Oral Pathol Med. 2018;47(6):557–565.
   PubMed Web of Science ®Google Scholar
• Capocasale G, Panzarella V, Tozzo P, et al. Oral verruciform xanthoma and erythroplakia associated with chronic graft-versus-host disease: a rare case report and review of the literature. BMC Res Notes. 2017 Nov 28;10(1):631.
   PubMedGoogle Scholar
• Villa A, Hanna GJ, Kacew A, et al., Oral keratosis of unknown significance shares genomic overlap with oral dysplasia. Oral Dis. 25(7): 1707–1714. 2019.
   PubMed Web of Science ®Google Scholar
• Woo SB, Grammer RL, Lerman MA. Keratosis of unknown significance and leukoplakia: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118(6):713–724.
   PubMed Web of Science ®Google Scholar
• Anderson A, Ishak N. Marked variation in malignant transformation rates of oral leukoplakia. Evid Based Dent. 2015;16(4):102–103.
   PubMedGoogle Scholar
• Wang YY, Tail YH, Wang WC, et al. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders. BMC Oral Health. 2014;14(1):99. 14:.
   PubMedGoogle Scholar
• Warnakulasuriya S. Ariyawardana A Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med. 2016;45(3):155–166.
   PubMed Web of Science ®Google Scholar
• Mehanna HM, Rattay T, Smith J, et al. Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis Head Neck. Head & Neck. 2009 Dec;31(12):1600–1609.
   PubMed Web of Science ®Google Scholar
• Cowan CG, Gregg TA, Napier SS, et al. Potentially malignant oral lesions in Northern Ireland: a 20-year population-based perspective of malignant transformation. Oral Dis. 2001;7(1):18–24.
   PubMed Web of Science ®Google Scholar
• Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003;14(1):47–62.
   PubMedGoogle Scholar
• Fleskens S, Slootweg P. Grading systems in head and neck dysplasia: their prognostic value, weaknesses and utility. Head Neck Oncol. 2009;1(1):11.
   PubMedGoogle Scholar
• Kujan O, Oliver RJ, Khattab A, et al. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol. 2006;42(10):987–993.
   PubMed Web of Science ®Google Scholar
• Macey R, Walsh T, Brocklehurst P, et al. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev. 2015 May 29;2015(5):CD010276.
   Google Scholar
• Mello FW, Miguel AFP, Dutra KL, et al. Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis. J Oral Pathol Med. 2018;47(7):633–640.
   PubMed Web of Science ®Google Scholar
• Nankivell P, Williams H, Matthews P, et al. The binary oral dysplasia grading system: validity testing and suggested improvement. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115(1):87–94.
   PubMed Web of Science ®Google Scholar
• Thomson PJ, Goodson ML, Smith DR. Treatment resistance in potentially malignant disorders—‘Nature’ or ‘Nurture’ … ? J Oral Pathol Med. 2017;46(10):902–910.
   PubMed Web of Science ®Google Scholar
• Ho MW, Field EA, Field JK, et al. Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic. Br J Oral Maxillofacial Surg. 2013;51(7):594–599.
   PubMed Web of Science ®Google Scholar
• Güneri P, Epstein JB, Sarode GS, et al. Why are we still unable to accurately determine the malignant potential or the behavior of oral mucosal lesions? Oral Oncol. 2017;71:177–179.
   PubMedGoogle Scholar
• Abadeh A, Ali AA, Bradley G, et al. Increase in detection of oral cancer and precursor lesions by dentists: evidence from an oral and maxillofacial pathology service. J Am Dental Assoc. 2019;150(6):531–539.
   PubMed Web of Science ®Google Scholar
• Lingen MW, Abt E, Agrawal N, et al. Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: a report of the American Dental Association. J Am Dental Assoc. 2017;148(10):712–727. e10.
   PubMed Web of Science ®Google Scholar
• Brothwell DJ, Lewis DW, Bradley G, et al. Observer agreement in the grading of oral epithelial dysplasia. Community Dent Oral Epidemiol. 2003;31(4):300–305.
   PubMed Web of Science ®Google Scholar
• Eversole LR. Dysplasia of the upper aerodigestive tract squamous epithelium. Head Neck Pathol. 2009;3(1):63–68.
   PubMedGoogle Scholar
• Mello FW, Melo G, ENdS G, et al. Prognostic biomarkers for malignant transformation of oral potentially malignant disorders: a scoping review protocol. JBI Evidence Synth. 2020;18(6):1349–1357.
   PubMedGoogle Scholar
• Warnakulasuriya S. Clinical features and presentation of oral potentially malignant disorders. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):582–590.
   PubMed Web of Science ®Google Scholar
• Dionne KR, Warnakulasuriya S, Zain RB, et al. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. Int J Cancer. 2015 Feb 1 136;(3)503–515.
   PubMed Web of Science ®Google Scholar
• Warnakulasuriya S, Kovacevic T, Madden P, et al. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med. 2011;40(9):677–683.
   PubMed Web of Science ®Google Scholar
• Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6(5):963–968.
   PubMed Web of Science ®Google Scholar
• Angadi PV, Savitha JK, Rao SS, et al. Oral field cancerization: current evidence and future perspectives Oral and Maxillofacial Surgery. Oral and Maxillofacial Surgery. 2012;16(2):171–180.
   PubMedGoogle Scholar
• Feller R, Lemmer J. Field Cancerization and Oral Leukoplakia. In: Dakubo GD, editor. Field Cancerization. Hauppauge NY, USA: Nova Science Publishers Inc. 2011.95–111.
   Google Scholar
• Mohan M, Jagannathan N. Oral field cancerization: an update on current concepts. Oncol Rev. 2014 Jun 30:8(1): 244. 13–19.
   PubMedGoogle Scholar
• Slaughter DP. Multicentric origin of intraoral carcinoma. Surgery. 1946;20(1):133–146.
   PubMed Web of Science ®Google Scholar
• Willis RA. The Mode of Origin of Tumors Solitary Localized Squamous Cell Growths of the Skin. Cancer Res. 1944;4(10):630–644.
   Google Scholar
• Califano J, Van Der Riet P, Westra W, et al. Genetic Progression Model for Head and Neck Cancer: implications for Field Cancerization. Cancer Res. 1996;56(11):2488–2492.
   PubMed Web of Science ®Google Scholar
• Alsahafi E, Begg K, Amelio I, et al. Clinical update on head and neck cancer: molecular biology and ongoing challenges. Cell Death Dis. 2019;10(8):540.
   PubMedGoogle Scholar
• Jou A, Epidemiology HJ. Molecular Biology of Head and Neck Cancer Oncol Res Treat. Oncology Research and Treatment. 2017;40(6):328–332.
   PubMed Web of Science ®Google Scholar
• Leemans CR, Braakhuis BJM, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11(1):p. 9–22.
   PubMed Web of Science ®Google Scholar
• Paliga A, Mai KT. Squamous cell carcinomas of the anterior oral cavity are commonly associated with simplex (or differentiated) oral intraepithelial neoplasia: clinical and pathologic significance. Int J Surg Pathol. 2014;22(3):231–240.
   PubMed Web of Science ®Google Scholar
• Tsantoulis PK, Kastrinakis NG, Tourvas AD, et al. Advances in the biology of oral cancer. Oral Oncol. 2007;43(6):p. 523–534.
   PubMed Web of Science ®Google Scholar
• Ryser MD, Lee WT, Ready NE, et al., Quantifying the dynamics of field cancerization in tobacco-related head and neck cancer: a multiscale modeling approach. Cancer Res. 76(24): 7078–7088. 2016.
   PubMed Web of Science ®Google Scholar
• Fearon ER. Vogelstein B A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759–767.
   PubMed Web of Science ®Google Scholar
• Steinbeck RG. Dysplasia in view of the cell cycle. Eur J Histochem. 2004 Jul-Sep;48(3):203–211.
   PubMed Web of Science ®Google Scholar
• Liu KYP, Lu XJD, Cheng YSL, et al. An actionable test using loss of heterozygosity in identifying high-risk oral premalignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;126(1):54–62.
   Web of Science ®Google Scholar
• Zhang L, Poh CF, Williams M, et al. Loss of heterozygosity (LOH) profiles-validated risk predictors for progression to oral cancer. Cancer Prev Res. 2012;5(9):1081–1089.
   PubMed Web of Science ®Google Scholar
• Tabor MP, Braakhuis BJM, Van Der Wal JE, et al. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx. J Pathol. 2003;199(3):354–360.
   PubMed Web of Science ®Google Scholar
• Rubin H. Fields and field cancerization: the preneoplastic origins of cancer: asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture. Bioessays. 2011 Mar;33(3):224–231.
   PubMed Web of Science ®Google Scholar
• Rubin H. Dynamics of cell transformation in culture and its significance for tumor development in animals. Proc Natl Acad Sci U S A. 2017;114(46):12237–12242.
   PubMed Web of Science ®Google Scholar
• Rubin H, Rubin AL. Phenotypic selection as the biological mode of epigenetic conversion and reversion in cell transformation. Proc Natl Acad Sci U S A. 2018;115(4):E725–E732.
   PubMed Web of Science ®Google Scholar
• Abdalla Z, Walsh T, Thakker N, et al. Loss of epithelial markers is an early event in oral dysplasia and is observed within the safety margin of dysplastic and T1 OSCC biopsies. PLoS One. 2017;12(12):12.
   Web of Science ®Google Scholar
• Anura A, Das RK, Pal M, et al. Correlated analysis of semi-quantitative immunohistochemical features of E-cadherin, VEGF and CD105 in assessing malignant potentiality of oral submucous fibrosis. Pathol Res Pract. 2014;210(12):1054–1063.
   PubMed Web of Science ®Google Scholar
• Sathish II, Asokan K, Krithika C, et al. Expression of E- Cadherin and Levels of Dysplasia in Oral Leukoplakia - A Prospective Cohort Study. Asian Pac J Cancer Prev. 2020;21(2):405–410.
   PubMedGoogle Scholar
• Jackson LL, Wade Z, Hessler RB, et al. Quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity. Laryngoscope. 2007;117(5):868–871.
   PubMed Web of Science ®Google Scholar
• Kamat SS, Kumar GS, Koshy AV. Immunohistochemical analysis of syndecan-1 in leukoplakia and oral submucous fibrosis. Dent Res J (Isfahan). 2013;10(3):321–327.
   PubMedGoogle Scholar
• Iozzo RV, Schaefer L. Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol. 2015;42:11–55.
   PubMed Web of Science ®Google Scholar
• Juneja S, Chaitanya NB, Agarwal M. Immunohistochemical expression of Bcl-2 in oral epithelial dysplasia and oral squamous cell carcinoma. Indian J Cancer. 2015;52(4):505–510.
   PubMed Web of Science ®Google Scholar
• Nitya K, Madhushankari GS, Basandi PS, et al. Bcl-2 expression in reactive oral lesions with atypical epithelium and in oral epithelial dysplasia associated with carcinogen exposure. J Oral Maxillofacial Pathol. 2019;23(2):306–3060.
   PubMedGoogle Scholar
• Whyte DA, Broton CE, Shillitoe EJ. The unexplained survival of cells in oral cancer: what is the role of p53? J Oral Pathol Med. 2002;31(3):125–133.
   PubMed Web of Science ®Google Scholar
• Maetzel D, Denzel S, Mack B, et al. Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol. 2009;11(2):162–171.
   PubMed Web of Science ®Google Scholar
• Somasundaram RT, Kaur J, Leong I, et al. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis. BMC Cancer. 2016;16(1):1.
   Google Scholar
• Pegoraro AF, Fredberg JJ, Park JA. Problems in biology with many scales of length: cell-cell adhesion and cell jamming in collective cellular migration. Exp Cell Res. 2016 10;343(1):54–59.
   PubMed Web of Science ®Google Scholar
• Sharma Y, Atia L, Rhodes CS, et al. Scaling Physiologic Function from Cell to Tissue in Asthma, Cancer, and Development. Ann Am Thorac Soc. 2018 Feb;15(Suppl 1):S35–S37.
   PubMedGoogle Scholar
• Eisenhoffer GT, Loftus PD, Yoshigi M, et al. Crowding induces live cell extrusion to maintain homeostatic cell numbers in epithelia. Nature. 2012;484(7395):546–549.
   PubMed Web of Science ®Google Scholar
• Gudipaty SA, Rosenblatt J. Epithelial cell extrusion: pathways and pathologies. Semin Cell Dev Biol. 2017 Jul;67:132–140.
   PubMed Web of Science ®Google Scholar
• Edwards PC. The natural history of oral epithelial dysplasia: perspective on Dost et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(3):263–266.
   PubMed Web of Science ®Google Scholar
• Rosa EA, Hurtado-Puerto AM, Falcão DP, et al. Oral lichen planus and malignant transformation: the role of p16, Ki-67, Bub-3 and SOX4 in assessing precancerous potential. Exp Ther Med. 2018;15(5):4157–4166.
   PubMed Web of Science ®Google Scholar
• Tampa M, Caruntu C, Mitran M, et al. Markers of oral lichen planus malignant transformation. Dis Markers. 2018 Feb 26;2018:1959506.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review. J Am Dent Assoc. 2014 Jan;145(1):45–56.
   PubMed Web of Science ®Google Scholar
• Aghbari SMH, Abushouk AI, Attia A, et al. Malignant transformation of oral lichen planus and oral lichenoid lesions: a meta-analysis of 20095 patient data. Oral Oncol. 2017 May;68:92–102.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick SG, Honda KS, Sattar A, et al. Histologic lichenoid features in oral dysplasia and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(4):511–520.
   PubMed Web of Science ®Google Scholar
• Davidova LA, Fitzpatrick SG, Bhattacharyya I, et al. Lichenoid Characteristics in Premalignant Verrucous Lesions and Verrucous Carcinoma of the Oral Cavity. Head Neck Pathol. 2019 Dec;13(4):573–579.
   PubMed Web of Science ®Google Scholar
• Leonardelli GB, Talmazzi F. Leucoplasie del Cavo Orale e Precancerosi, Nota I. Arch Ital Otol. 1950;61:107–114.
   PubMedGoogle Scholar
• Pindborg JJ, Renstrup G, Poulsen HE, et al. Studies in oral leukoplakias V. Clinical and histologic signs of malignancy. Acta Odontol Scand. 1963;21(5):407–414.
   PubMedGoogle Scholar
• Smith CJ, Pindborg JJ. Histological grading of oral epithelial atypia by the use of photographic standard C. Copenhagen: Hamburgers Bogtrykkeri; 1969.
   Google Scholar
• Ranganathan K, Kavitha L. Oral epithelial dysplasia: classifications and clinical relevance in risk assessment of oral potentially malignant disorders. J Oral Maxillofacial Pathol. 2019;23(1):19–27.
   PubMedGoogle Scholar
• Abram TJ, Floriano PN, Christodoulides N, et al. ‘Cytology-on-a-chip’ based sensors for monitoring of potentially malignant oral lesions. Oral Oncol. 2016;60:103–111.
   PubMed Web of Science ®Google Scholar
• Izumo T. Oral premalignant lesions: from the pathological viewpoint. Int J Clin Oncol. 2011 Feb;16(1):15–26.
   PubMed Web of Science ®Google Scholar
• Sadiq H, Gupta P, Singh N, et al. Various grading systems of oral epithelial dysplasia: a review. Int J Adv Health Sci. 2015;1:20–26.
   Google Scholar
• Warnakulasuriya S, Reibel J, Bouquot J, et al. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med. 2008;37(3):p. 127–133.
   Web of Science ®Google Scholar
• Wils LJ, Poell JB, Evren I, et al. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression. Mod Pathol. 2020;33(6):1033–1040.
   PubMed Web of Science ®Google Scholar
• Geetha KM, Leeky M, Narayan TV, et al. Grading of oral epithelial dysplasia: points to ponder. J Oral Maxillofacial Pathol. 2015;19(2):198–204.
   PubMedGoogle Scholar
• Katz H, Shear M, Altini M. A critical evaluation of epithelial dysplasia in oral mucosal lesions using the Smith‐Pindborg method of standardization. J Oral Pathol Med. 1985;14(6):476–482.
   Web of Science ®Google Scholar
• Manchanda A, Shetty DC. Reproducibility of grading systems in oral epithelial dysplasia. Med Oral Patologia Oral Y Cirugia Bucal. 2012;17(6):6.
   Web of Science ®Google Scholar
• Speight PM, Abram TJ, Floriano PN, et al. Interobserver agreement in dysplasia grading: toward an enhanced gold standard for clinical pathology trials. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(4):474–482. e2.
   PubMed Web of Science ®Google Scholar
• Holmstrup P, Vedtofte P, Reibel J, et al. Oral premalignant lesions: is a biopsy reliable? J Oral Pathol Med. 2007;36(5):262–266.
   PubMed Web of Science ®Google Scholar
• AbdulMajeed AA, Farah CS. Can Immunohistochemistry Serve as an Alternative to Subjective Histopathological Diagnosis of Oral Epithelial Dysplasia? Biomark Cancer. 2013;5:S12951. [ BIC.S12951-BIC].
   Google Scholar
• De Morais EF, Pinheiro JC, Lira JAS, et al. Prognostic value of the immunohistochemical detection of epithelial-mesenchymal transition biomarkers in oral epithelial dysplasia: a systematic review. Med Oral S L. 2020;25(2):e205–e216.
   Google Scholar
• Hirshberg A, Allon I, Novikov I, et al. Gold nanorods reflectance discriminate benign from malignant oral lesions. Nanomed. 2017;13(4):1333–1339.
   PubMed Web of Science ®Google Scholar
• Ikeda M, Shima K, Kondo T, et al. Atypical immunohistochemical patterns can complement the histopathological diagnosis of oral premalignant lesions. J Oral Biosci. 2020;62(1):93–98.
   PubMedGoogle Scholar
• Liu SC, Hu Y, Sauter ER, et al. Image analysis of p53 and cyclin D1 expression in premalignant lesions of the oral mucosa. Anal Quant Cytology Histol. 1999;21(2):166–173.
   PubMedGoogle Scholar
• Macabeo-Ong M, Shiboski CH, Silverman S, et al. Quantitative analysis of cathepsin L mRNA and protein expression during oral cancer progression. Oral Oncol. 2003;39(7):638–647.
   PubMed Web of Science ®Google Scholar
• Babiuch K, Kuśnierz-Cabala B, Kęsek B, et al. Evaluation of Proinflammatory, NF-kappaB Dependent Cytokines: IL-1α, IL-6, IL-8, and TNF-α in Tissue Specimens and Saliva of Patients with Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders. J Clin Med. 2020;9(3):867–8670.
   Web of Science ®Google Scholar
• Siril YJ, Kouketsu A, Oikawa M, et al. Immunohistochemical assessment of chromatin licensing and DNA replication factor 1, geminin, and γ-H2A.X in oral epithelial precursor lesions and squamous cell carcinoma. J Oral Pathol Med. 2019;48(10):888–896.
   PubMed Web of Science ®Google Scholar
• Tashiro K, Oikawa M, Miki Y, et al. Immunohistochemical assessment of growth factor signaling molecules: MAPK, Akt, and STAT3 pathways in oral epithelial precursor lesions and squamous cell carcinoma. Odontology. 2020;108(1):91–101.
   PubMed Web of Science ®Google Scholar
• Baran CA, Agaimy A, Wehrhan F, et al. MAGE-A expression in oral and laryngeal leukoplakia predicts malignant transformation. Mod Pathol. 2019;32(8):1068–1081.
   PubMed Web of Science ®Google Scholar
• Priyanka KP, Majumdar S, Kotina S, et al. Expression of heat shock protein 70 in oral epithelial dysplasia and oral squamous cell carcinoma: an immunohistochemical study. Contemp Clin Dent. 2019;10(2):185–190.
   PubMed Web of Science ®Google Scholar
• Philipone E, Yoon AJ, Wang S, et al. MicroRNAs-208b-3p, 204-5p, 129-2-3p and 3065-5p as predictive markers of oral leukoplakia that progress to cancer. Am J Cancer Res. 2016;6(7):1537–15370.
   PubMed Web of Science ®Google Scholar
• Abram TJ, Floriano PN, James R, et al. Development of a cytology-based multivariate analytical risk index for oral cancer. Oral Oncol. 2019;92:6–11.
   PubMed Web of Science ®Google Scholar
• McRae MP, Modak SS, Simmons GW, et al. Point-of-care oral cytology tool for the screening and assessment of potentially malignant oral lesions. Cancer Cytopathol. 2020;128(3):207–220.
   PubMed Web of Science ®Google Scholar
• Cherry KD, Schwarz RA, Yang EC, et al. Autofluorescence imaging to monitor the progression of oral potentially malignant disorders. Cancer Prev Res. 2019;12(11):791–799.
   PubMed Web of Science ®Google Scholar
• Duran-Sierra E, Cheng S, Cuenca-Martinez R, et al. Clinical label-free biochemical and metabolic fluorescence lifetime endoscopic imaging of precancerous and cancerous oral lesions. Oral Oncol. 2020 Jun;105:104635. Epub 2020 Apr 2.
   PubMedGoogle Scholar
• Santosh N, McNamara KK, Beck FM, et al. Expression of cornulin in oral premalignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127(6):526–534.
   PubMed Web of Science ®Google Scholar
• Dost F, Lê Cao K, Ford PJ, et al. Malignant transformation of oral epithelial dysplasia: a real-world evaluation of histopathologic grading. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(3):343–352.
   PubMed Web of Science ®Google Scholar
• Gadiwan M, Madhushankari GS, Mandana DD, et al. Nuclear features in different grades of epithelial dysplasia in leukoplakia: a computer assisted microscopic study. J Oral Maxillofacial Pathol. 2014;18(2):194–200.
   PubMedGoogle Scholar
• Giaretti W, Monteghirfo S, Pentenero M, et al. Chromosomal instability, DNA index, dysplasia, and subsite in oral premalignancy as intermediate endpoints of risk of cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(6):1133–1141.
   PubMed Web of Science ®Google Scholar
• Yang X, Xiao X, Wu W, et al. Cytological study of DNA content and nuclear morphometric analysis for aid in the diagnosis of high-grade dysplasia within oral leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;124(3):280–285.
   PubMed Web of Science ®Google Scholar
• Okamura T, Izumo T, Yagishita H, et al. Disordered arrangements of basal cells as a prognostic factor for oral epithelial dysplasia: a morphometric study of 96 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(3):355–361.
   PubMed Web of Science ®Google Scholar
• Gadbail AR, Chaudhary M, Sarode SC, et al. Ki67, CD105, and α-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis. PLoS One. 2018;13(7):7.
   Web of Science ®Google Scholar
• Hande A, Chaudhary M, Gawande M, et al. Oral submucous fibrosis: an enigmatic morpho-insight. J Cancer Res Ther. 2019 Jul-Sep;15(3):463–469.
   PubMed Web of Science ®Google Scholar
• Sarode SC, Chaudhary M, Gadbail A, et al. Dysplastic features relevant to malignant transformation in atrophic epithelium of oral submucous fibrosis: a preliminary study. J Oral Pathol Med. 2018;47(4):410–416.
   PubMed Web of Science ®Google Scholar
• Kujan O, Mello FW, Warnakulasuriya S. Malignant transformation of oral submucous fibrosis: a systematic review and meta-analysis. Oral Dis. 2020 Nov 18. 10.1111/odi.13727.. Online ahead of print.
   Web of Science ®Google Scholar
• Monteiro L, Mello FW, Warnakulasuriya S. Tissue Biomarkers for Predicting the Risk of Oral Cancer in Patients Diagnosed with Oral Leukoplakia. A Systematic Review. Oral Dis. 2020 Dec 8. 10.1111/odi.13747.. Online ahead of print.
   Web of Science ®Google Scholar
• Rodríguez-Blanco I, Á F, Paredes-Suárez C, et al. Actinic cheilitis: analysis of clinical subtypes, risk factors and associated signs of actinic damage Acta D-V. IEEE .. International Conference on Rehabilitation Robotics : [Proceedings]. 2019;2019(p):931–932.
   PubMedGoogle Scholar
• Mello FW, Melo G, Modolo F, et al., Actinic cheilitis and lip squamous cell carcinoma: literature review and new data from Brazil. J Clin Exp Dent. 11(1): e62–e69. 2019.
   PubMedGoogle Scholar
• Câmara PR, Dutra SN, Takahama Júnior A, et al. A comparative study using WHO and binary oral epithelial dysplasia grading systems in actinic cheilitis. Oral Dis. 2016;22(6):523–529.
   PubMed Web of Science ®Google Scholar
• De Santana Sarmento DJ, Da Costa Miguel MC, Queiroz LMG, et al. Actinic cheilitis: clinicopathologic profile and association with degree of dysplasia. Int J Dermatol. 2014;53(4):466–472.
   PubMed Web of Science ®Google Scholar
• Gonzaga AKG, Mafra RP, Da Silva LP, et al. Actinic cheilitis: morphometric parameters and its relationship with the degree of epithelial dysplasia. Acta Histochem. 2020 Jan;122(1):151452. Epub 2019 Sep 23.
   PubMed Web of Science ®Google Scholar
• Dancyger A, Heard V, Huang B, et al. Malignant transformation of actinic cheilitis: a systematic review of observational studies. J Investig Clin Dent. 2018;9(4):e12343–e12343.
   PubMed Web of Science ®Google Scholar
• Nagata G, Santana T, Queiroz A, et al. Evaluation of epithelial dysplasia adjacent to lip squamous cell carcinoma indicates that the degree of dysplasia is not associated with the occurrence of invasive carcinoma in this site. J Cutan Pathol. 2018;45(9):647–651.
   Web of Science ®Google Scholar
• Santana T, Matuck B, Tenório JR, et al. Can immunohistochemical biomarkers distinguish epithelial dysplasia degrees in actinic cheilitis? A systematic review and meta-analysis. Med Oral S L. 2020;25(1):e106–e116.
   Google Scholar
• Cheng YSL, Gould A, Kurago Z, et al. Diagnosis of oral lichen planus: a position paper of the American Academy of Oral and Maxillofacial Pathology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(3):332–354.
   PubMed Web of Science ®Google Scholar
• Richards D. Malignant transformation rates in Oral Lichen Planus. Evid Based Dent. 2018 Dec;19(4):122.
   PubMedGoogle Scholar
• Shearston K, Fateh B, Tai S, et al., Oral lichenoid dysplasia and not oral lichen planus undergoes malignant transformation at high rates. J Oral Pathol Med. 48(7): 538–545. 2019.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Moles MA, Warnakulasuriya S, Gonzalez-Ruiz I, et al. Worldwide prevalence of oral lichen planus: a systematic review and meta-analysis. Oral Dis. 2020 Mar 7. 10.1111/odi.13323.. [ Online ahead of print].
   Web of Science ®Google Scholar
• Gonzalez-Moles MA, Ramos-Garcia P, Warnakulasuriya S. An appraisal of highest quality studies reporting malignant transformation of oral lichen planus based on a systematic review. Oral Dis. 2020 Dec 3. 10.1111/odi.13741.. Online ahead of print.
   Web of Science ®Google Scholar
• Gonzalez-Moles MA, Ruiz-Avila I, Gonzalez-Ruiz L, et al. Malignant transformation risk of oral lichen planus: a systematic review and comprehensive meta-analysis. Oral Oncol. 2019 Sep;96:121–130.
   PubMed Web of Science ®Google Scholar
• Guan G, Mei L, Polonowita A, et al. Malignant transformation in oral lichen planus and lichenoid lesions: a 14-year longitudinal retrospective cohort study of 829 patients in New Zealand. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Oct;130(4):411–418.
   PubMed Web of Science ®Google Scholar
• Shailaja G, Kumar J, Baghirath P, et al. Estimation of malignant transformation rate in cases of oral epithelial dysplasia and lichen planus using immunohistochemical expression of Ki-67, p53, BCL-2, and BAX markers. Dent Res J (Isfahan). 2015;12(3):235–242.
   PubMedGoogle Scholar
• Bosman FT. Dysplasia classification: pathology in disgrace? J Pathol. 2001;194(2):p. 143–144.
   PubMed Web of Science ®Google Scholar
• Eaden J, Abrams K, McKay H, et al. Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J Pathol. 2001;194(2):152–157.
   PubMed Web of Science ®Google Scholar
• Grenko RT, Abendroth CS, Frauenhoffer EE, et al. Variance in the interpretation of cervical biopsy specimens obtained for atypical squamous cells of undetermined significance. Am J Clin Pathol. 2000;114(5):735–740.
   PubMed Web of Science ®Google Scholar
• Van Sandick JW, Baak JPA, Jjb VL, et al. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett’s oesophagus. J Pathol. 2000;190(2):177–183.
   PubMed Web of Science ®Google Scholar
• Bauer GM, Stypula-Cyrus Y, Subramanian H, et al. The transformation of the nuclear nanoarchitecture in human field carcinogenesis. Future Sci OA . 2017 May 5;3(3): FSO206. 10.4155/fsoa-2017-0027
   PubMed Web of Science ®Google Scholar
• Hwang JT, Gu YR, Shen M, et al. Individualized five-year risk assessment for oral premalignant lesion progression to cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Mar;123(3):374–381.
   PubMed Web of Science ®Google Scholar
• Amenábar JM, Da Silva BM, Punyadeera C. Salivary protein biomarkers for head and neck cancer. Expert Rev Mol Diagn. 2020 Mar;20(3):305–313.
   PubMed Web of Science ®Google Scholar
• Jayalekshmi PA, Gangadharan P, Akiba S, et al. Oral cavity cancer risk in relation to tobacco chewing and bidi smoking among men in Karunagappally, Kerala, India: karunagappally cohort study. Cancer Sci. 2011;102(2):460–467.
   PubMed Web of Science ®Google Scholar
• Morse DE, Katz RV, Pendrys DG, et al. Smoking and drinking in relation to oral epithelial dysplasia. Cancer Epidemiol Biomarkers Prev. 1996;5(10):769–777.
   PubMed Web of Science ®Google Scholar
• Morse DE, Psoter WJ, Cleveland D, et al., Smoking and drinking in relation to oral cancer and oral epithelial dysplasia. Cancer Causes Control. 18(9): 919–929. 2007.
   PubMed Web of Science ®Google Scholar
• Muwonge R, Ramadas K, Sankila R, et al. Role of tobacco smoking, chewing and alcohol drinking in the risk of oral cancer in Trivandrum, India: a nested case-control design using incident cancer cases. Oral Oncol. 2008;44(5):446–454.
   PubMed Web of Science ®Google Scholar
• Riedel F, Goessler UR, Hörmann K. Alcohol-related diseases of the mouth and throat. Dig Dis. 2006;23(3–4):195–203.
   Web of Science ®Google Scholar
• Kaugars GE, Brandt RB, Chan W, et al. Evaluation of risk factors in smokeless tobacco-associated oral lesions. Oral Surg Oral Med Oral Pathol. 1991;72(3):326–331.
   PubMedGoogle Scholar
• De Oliveira Semenzati G, De Souza Salgado B, Rocha NS, et al. Histological and immunohistochemical study of the expression of p53 and ki-67 proteins in the mucosa of the tongue, pharynx and larynx of rats exposed to cigarette smoke. Inhal Toxicol. 2012 Sep;24(11):723–731.
   PubMed Web of Science ®Google Scholar
• Garcia Martins RH, Marques Madeira SL, Fabro AT, et al. Effects to exposure of tobacco smoke and alcohol on the tongue and pharynx of rats. Inhal Toxicol. 2012;24(3):153–160.
   PubMed Web of Science ®Google Scholar
• Balansky R, Ganchev G, Iltcheva M, et al. Potent carcinogenicity of cigarette smoke in mice exposed early in life. Carcinogenesis. 2007;28(10):2236–2243.
   PubMed Web of Science ®Google Scholar
• Dost F, Lê Cao KA, Ford PJ, et al. A retrospective analysis of clinical features of oral malignant and potentially malignant disorders with and without oral epithelial dysplasia Oral Surgery. Oral Med Oral Pathol Oral Radiol. 2013;116(6):725–733.
   PubMed Web of Science ®Google Scholar
• Mincer HH, Coleman SA, Hopkins KP. Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg Oral Med Oral Pathol. 1972;33(3):389–399.
   PubMedGoogle Scholar
• Benner SE, Winn RJ, Lippman SM, et al. Regression of oral leukoplakia with α-tocopherol: a community clinical oncology program chemoprevention study. J Natl Cancer Inst. 1993;85(1):44–47.
   PubMedGoogle Scholar
• Vincent-Chong VK, DeJong H, Attwood K, et al. Preclinical Prevention Trial of Calcitriol: impact of Stage of Intervention and Duration of Treatment on Oral Carcinogenesis. Neoplasia (United States). 2019;21(4):376–388.
   PubMed Web of Science ®Google Scholar